Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I Interferons
Xiangzhi Meng(University of California, Los Angeles), Yan Xiang(Sichuan University), Kevin Dick(Children's Hospital of Eastern Ontario), Jingxin Cao(Public Health Agency of Canada), Canhua Jiang(Central South University), Janilyn Arsenio(University of Manitoba)
Cited by 70
Related Papers
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
|Nature|2021|216
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
|ACS Central Science|2021|200
The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
|Emerging Microbes & Infections|2021|190
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
|Journal of Medicinal Chemistry|2021|168